Tag: Pharmaceutical

• GRI Bio Reports Positive Phase 2a Topline Data for GRI-0621

  December 22, 2025

  Industry News

  GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic pulmonary fibrosis...

  Read More

• MajesTEC-3 Puts a New Immunotherapy Doublet in the Spotlight

  December 22, 2025

  Industry News

  Johnson & Johnson has reported what it describes as unprecedented phase 3 results from the MajesTEC-3 study, positioning TECVAYLI...

  Read More

• European Commission Clears Johnson & Johnson’s IMAAVY

  December 15, 2025

  Industry News

  Johnson & Johnson has secured European Commission (EC) approval for nipocalimab, to be marketed as IMAAVY, as an add-on...

  Read More

• Evotec and Bayer Advance Novel Antibody into Phase 2 Trial for Alport Syndrome

  December 15, 2025

  Industry News

  Evotec SE has announced a key clinical milestone in its long-standing kidney disease partnership with Bayer AG, as Bayer...

  Read More

• MSD’s Deal Puts Spotlight on hVIVO’s Role in Next-Generation Flu Protection

  December 8, 2025

  Industry News

  Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion,...

  Read More

• eXmoor Pharma and Royal Free London Forge End-to-End Cell and Gene Therapy Pathway

  December 8, 2025

  Industry News

  eXmoor Pharma and the Royal Free London NHS Foundation Trust have announced a strategic collaboration designed to create a...

  Read More